BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21229642)

  • 41. Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
    Deininger MH; Grote E; Wickboldt J; Meyermann R
    J Neurooncol; 2000 Jun; 48(2):121-9. PubMed ID: 11083075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
    Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
    Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.
    Panicker SP; Raychaudhuri B; Sharma P; Tipps R; Mazumdar T; Mal AK; Palomo JM; Vogelbaum MA; Haque SJ
    Oncotarget; 2010 Aug; 1(4):289-303. PubMed ID: 21304179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of children with glioblastoma with conformal radiation, temozolomide, and bevacizumab as adjuncts to surgical resection.
    Friedman GK; Spiller SE; Harrison DK; Fiveash JB; Reddy AT
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):e123-6. PubMed ID: 23425999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
    Affronti ML; Heery CR; Herndon JE; Rich JN; Reardon DA; Desjardins A; Vredenburgh JJ; Friedman AH; Bigner DD; Friedman HS
    Cancer; 2009 Aug; 115(15):3501-11. PubMed ID: 19514083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
    Hainsworth JD; Ervin T; Friedman E; Priego V; Murphy PB; Clark BL; Lamar RE
    Cancer; 2010 Aug; 116(15):3663-9. PubMed ID: 20564147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Ioani H; Susman S; Petrescu M; Timis T; Cernea D; Kacso G; Irimie A; Florian IS
    J BUON; 2010; 15(3):583-91. PubMed ID: 20941832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation.
    Yuan M; Eberhart CG; Kai M
    Oncotarget; 2014 May; 5(9):2820-6. PubMed ID: 24811242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation.
    Battula VL; Bareiss PM; Treml S; Conrad S; Albert I; Hojak S; Abele H; Schewe B; Just L; Skutella T; Bühring HJ
    Differentiation; 2007 Apr; 75(4):279-91. PubMed ID: 17288545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
    Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS
    Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.
    Dahan P; Martinez Gala J; Delmas C; Monferran S; Malric L; Zentkowski D; Lubrano V; Toulas C; Cohen-Jonathan Moyal E; Lemarie A
    Cell Death Dis; 2014 Nov; 5(11):e1543. PubMed ID: 25429620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells.
    Bou-Gharios J; Assi S; Bahmad HF; Kharroubi H; Araji T; Chalhoub RM; Ballout F; Harati H; Fares Y; Abou-Kheir W
    Pharmacol Rep; 2021 Feb; 73(1):227-239. PubMed ID: 33140310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.
    D'Alimonte I; Nargi E; Zuccarini M; Lanuti P; Di Iorio P; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Ciccarelli R
    Purinergic Signal; 2015 Sep; 11(3):331-46. PubMed ID: 25976165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
    Yun HS; Lee J; Kil WJ; Kramp TR; Tofilon PJ; Camphausen K
    Mol Cancer Ther; 2021 Sep; 20(9):1672-1679. PubMed ID: 34158343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation.
    Li H; Liu Y; Jiao Y; Guo A; Xu X; Qu X; Wang S; Zhao J; Li Y; Cao Y
    Oncol Rep; 2016 Jan; 35(1):343-51. PubMed ID: 26498391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
    Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular analysis of a recurrent glioblastoma treated with bevacizumab.
    Furuta T; Nakada M; Misaki K; Sato Y; Hayashi Y; Nakanuma Y; Hamada J
    Brain Tumor Pathol; 2014 Jan; 31(1):32-9. PubMed ID: 23504126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
    Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
    Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.